PureTech Health PLC

NASDAQ PRTC

Download Data

PureTech Health PLC Tangible Book Value per Share 1 year YoY Change (%) for the Trailing 12 Months (TTM) ending September 20, 2024

PureTech Health PLC Tangible Book Value per Share 1 year YoY Change (%) is NA for the Trailing 12 Months (TTM) ending September 20, 2024. Tangible book value per share represents the shareholders' equity (tangible) minus goodwill and intangible assets divided by the weighted average number of outstanding shares. It provides the value of tangible assets per share owned by the shareholders. This ratio helps investors assess the tangible asset value relative to the number of shares outstanding. The measure "Change (%)" refers to the percentage change in the value of a financial metric between two time points. This measure provides a relative perspective on the magnitude of change.
NASDAQ: PRTC

PureTech Health PLC

CEO Ms. Daphne Zohar
IPO Date Nov. 16, 2020
Location United States
Headquarters 6 Tide Street, Boston, MA, United States, 02210
Employees 90
Sector Healthcare
Industry Biotechnology
Description

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies. It also develops SPT-300, an oral drug of allopregnanolone for the treatment of anxious depression; SPT-320, a novel prodrug of agomelatine for the treatment of generalized anxiety disorder; and SPT-348, a prodrug of a non-hallucinogenic neuroplastogen for the treatment of mood and other neuropsychiatric disorders. In addition, the company is developing hydrogels to enable the oral administration of peptide therapeutics in preclinical development. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.

Similar companies

MNOV

MediciNova Inc

NA

NA

ANEB

Anebulo Pharmaceuticals Inc

NA

NA

CYT

Cyteir Therapeutics Inc

NA

NA

ELYM

Eliem Therapeutics Inc

NA

NA

ACRV

Acrivon Therapeutics Inc. Common Stock

NA

NA

JANX

Janux Therapeutics Inc

NA

NA

StockViz Staff

September 20, 2024

Any question? Send us an email